Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia 14Lymphoma, Large B-Cell, Diffuse 13Prostatic Neoplasms 11Lymphoma, Follicular 11Hodgkin Disease 11Burkitt Lymphoma 11Multiple Myeloma 7Lymphoma, Large-Cell, Anaplastic 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms, Plasma Cell 4Dendritic Cell Sarcoma, Interdigitating 4Waldenstrom Macroglobulinemia 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Immunoblastic Lymphadenopathy 2Cardiotoxicity 2Thymoma 1Thrombocytopenia 1Sezary Syndrome 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pain 1Neutropenia 1

Interventions

Taxes 2Paclitaxel 2Carboplatin 2Ramucirumab 1Proton Therapy 1Prednisone 1Octreotide 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Thymoma × Prednisone × Clear all
NCT00003283 2023-06-15

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Eastern Cooperative Oncology Group

Phase 2 Completed
38 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡